BNKL (Bionik Laboratories) Interest Expense: $-0.11 Mil (TTM As of Mar. 2023)


BNKL Bionik Laboratories Corp BNKL
12 GF Score
Price $0.00
View Full Analysis

What is Bionik Laboratories Interest Expense?

Bionik Laboratories BNKL -99.00% 12 Interest Expense is $-0.11 Mil as of Mar. 2023. GuruFocus rates BNKL with a GF Score™ of 12/100.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Bionik Laboratories's interest expense for the three months ended in Mar. 2023 was $ -0.05 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2023 was $-0.11 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Bionik Laboratories's Operating Income for the three months ended in Mar. 2023 was $ -1.30 Mil. Bionik Laboratories's Interest Expense for the three months ended in Mar. 2023 was $ -0.05 Mil. Bionik Laboratories did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bionik Laboratories  (OTCPK:BNKL) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bionik Laboratories's Interest Expense for the three months ended in Mar. 2023 was $-0.05 Mil. Its Operating Income for the three months ended in Mar. 2023 was $-1.30 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2023 was $2.39 Mil.

Bionik Laboratories's Interest Coverage for the quarter that ended in Mar. 2023 is calculated as

Bionik Laboratories did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Bionik Laboratories Interest Expense Historical Data

* Premium members only.

The historical data trend for Bionik Laboratories's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionik Laboratories Interest Expense Chart

Bionik Laboratories Annual Data
Trend Dec14 Dec15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.27 -0.18 -0.41 -0.83 -0.11

Bionik Laboratories Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.25 -0.01 -0.02 -0.03 -0.05
BNKL
12GF Score
Bionik Laboratories Corp BNKL
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bionik Laboratories Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.11 Mil mean?
Bionik Laboratories (BNKL) has a Interest Expense of $-0.11 Mil as of Mar. 2023. Interest Expense is the amount a company pays on its long-term debt. View historical data on Bionik Laboratories and its competitors.
Is Bionik Laboratories' Interest Expense too high?
Bionik Laboratories' current Interest Expense is $-0.11 Mil. Overall, Bionik Laboratories has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bionik Laboratories' Interest Expense compare to ARPC and GRST?
Bionik Laboratories' Interest Expense of $-0.11 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Healthcare Providers & Services company?
A good Interest Expense depends on the Healthcare Providers & Services industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Bionik Laboratories and its competitors. Bionik Laboratories's current Interest Expense is $-0.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionik Laboratories stock overvalued right now?
Bionik Laboratories (BNKL) has a current Interest Expense of $-0.11 Mil. The current Interest Expense is $-0.11 Mil. Bionik Laboratories' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Bionik Laboratories (BNKL), the current Interest Expense is $-0.11 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionik Laboratories Business Description

Address 80 Coolidge Hill Road, Watertown, MA, USA, 02472
Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.
12GF Score

Get the complete analysis for BNKL

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price